Cover Image
市場調查報告書

Mymetics Corporation:產品平台分析

Mymetics Corporation - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224650
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
Back to Top
Mymetics Corporation:產品平台分析 Mymetics Corporation - Product Pipeline Review - 2015
出版日期: 2015年06月30日 內容資訊: 英文 35 Pages
簡介

Mymetics Corporation是研究開發治療HIV(AIDS)、瘧疾、呼吸道融合病毒(RSV)及流感用的類病毒體疫苗及粘膜疫苗的的生物科技企業。

本報告提供Mymetics Corporation的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Mymetics Corporation的基本資料

Mymetics Corporation概要

  • 主要資訊
  • 企業資料

Mymetics Corporation:R&D概要

  • 主要的治療範圍

Mymetics Corporation:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Mymetics Corporation:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Mymetics Corporation:藥物簡介

  • MYM-V101
  • PEV-3
  • 流感疫苗
  • 單純皰疹病毒病用疫苗

Mymetics Corporation:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

Mymetics Corporation:最近的開發平台趨勢

Mymetics Corporation:暫停中的計劃

Mymetics Corporation:企業發表

Mymetics Corporation:總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07229CDB

Summary

Global Markets Direct's, 'Mymetics Corporation - Product Pipeline Review - 2015', provides an overview of the Mymetics Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Mymetics Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Mymetics Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Mymetics Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Mymetics Corporation's pipeline products

Reasons to buy

  • Evaluate Mymetics Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Mymetics Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Mymetics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Mymetics Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Mymetics Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Mymetics Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Mymetics Corporation Snapshot
    • Mymetics Corporation Overview
    • Key Information
    • Key Facts
  • Mymetics Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Mymetics Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Mymetics Corporation - Pipeline Products Glance
    • Mymetics Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Mymetics Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Mymetics Corporation - Drug Profiles
    • PEV-3
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • influenza vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MYMV-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • herpes simplex virus [type 1, 2] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MYMV-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Mymetics Corporation - Pipeline Analysis
    • Mymetics Corporation - Pipeline Products by Target
    • Mymetics Corporation - Pipeline Products by Route of Administration
    • Mymetics Corporation - Pipeline Products by Molecule Type
  • Mymetics Corporation - Recent Pipeline Updates
  • Mymetics Corporation - Dormant Projects
  • Mymetics Corporation - Company Statement
  • Mymetics Corporation - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Mymetics Corporation, Key Information
  • Mymetics Corporation, Key Facts
  • Mymetics Corporation - Pipeline by Indication, 2015
  • Mymetics Corporation - Pipeline by Stage of Development, 2015
  • Mymetics Corporation - Monotherapy Products in Pipeline, 2015
  • Mymetics Corporation - Partnered Products in Pipeline, 2015
  • Mymetics Corporation - Partnered Products/ Combination Treatment Modalities, 2015
  • Mymetics Corporation - Out-Licensed Products in Pipeline, 2015
  • Mymetics Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Mymetics Corporation - Phase II, 2015
  • Mymetics Corporation - Phase I, 2015
  • Mymetics Corporation - Preclinical, 2015
  • Mymetics Corporation - Discovery, 2015
  • Mymetics Corporation - Pipeline by Target, 2015
  • Mymetics Corporation - Pipeline by Route of Administration, 2015
  • Mymetics Corporation - Pipeline by Molecule Type, 2015
  • Mymetics Corporation - Recent Pipeline Updates, 2015
  • Mymetics Corporation - Dormant Developmental Projects,2015
  • Mymetics Corporation, Subsidiaries

List of Figures

  • Mymetics Corporation - Pipeline by Top 10 Indication, 2015
  • Mymetics Corporation - Pipeline by Stage of Development, 2015
  • Mymetics Corporation - Monotherapy Products in Pipeline, 2015
  • Mymetics Corporation - Pipeline by Top 10 Target, 2015
  • Mymetics Corporation - Pipeline by Top 10 Route of Administration, 2015
  • Mymetics Corporation - Pipeline by Top 10 Molecule Type, 2015
Back to Top